CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock Income Statement
NASDAQ:CRBP • US21833P3010
Current stock price
9.71 USD
-0.43 (-4.24%)
Last:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 880.00K | 3.94M | |||
| Operating Expenses | 49.00M | 45.00M | 34.84M | 56.87M | 126.75M | |||
| Research and Development | N/A | 31.17M | 16.14M | 36.45M | 98.27M | |||
| Selling, General, and Administrative Expenses | 16.00M | 14.00M | 18.70M | 20.43M | 28.48M | |||
| Operating Income | -49.00M | -45.00M | -34.84M | -55.99M | -122.81M | |||
| Interest Income/Expense | N/A | -2.92M | -2.46M | -1.55M | -1.73M | |||
| Other Income/Expense | 9.00M | 3.39M | -50.00K | 11.90M | 13.27M | |||
| Non Recurring Items | N/A | 0.00 | -5.00M | N/A | N/A | |||
| Income Before Taxes | -40.00M | -45.00M | -42.35M | -45.64M | -111.27M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -40.00M | -45.00M | -42.35M | -45.64M | -111.27M | |||
| EBITDA | -48.41M | -44.36M | -34.08M | -54.99M | -121.69M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.63 | -10.39 | -10.15 | -11.13 | -42.79 | |||
| Non GAAP EPS | -3.66 | -10.15 | -10.41 | -11.70 | -44.10 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -5186.36% | -2824.11% | |||
| Operating Profit Margin | N/A | N/A | N/A | -6362.50% | -3117.01% | |||
All data in USD